{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:03:18Z","timestamp":1790697798993,"version":"4.1.0"},"reference-count":87,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Idiopathic inflammatory myopathies are a group of rare connective tissue diseases with a well-documented association with malignancy. The mechanisms underlying the increased risk of neoplasms in the course of myositis are not fully understood. The Pubmed database has been thoroughly screened for articles concerning cancer-associated myositis (CAM). The article summarizes the current state of knowledge on the epidemiology and pathogenesis of CAM. Furthermore, it analyses potential risk and protective factors for developing CAM, with particular emphasis on the association with distinct serological profiles. The review summarizes recommendations proposed so far for the management of CAM and presents a novel scheme for cancer screening proposed by the authors. Moreover, promising areas requiring further research were indicated.<\/jats:p>","DOI":"10.3390\/biom12010111","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T14:05:07Z","timestamp":1641909907000},"page":"111","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Update on Malignancy in Myositis\u2014Well-Established Association with Unmet Needs"],"prefix":"10.3390","volume":"12","author":[{"given":"Aleksandra H.","family":"Opinc","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Medical University of Lodz, \u017beromskiego 113, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna S.","family":"Makowska","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Medical University of Lodz, \u017beromskiego 113, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","article-title":"Incidence and prevalence of inflammatory myopathies: A systematic review","volume":"54","author":"Meyer","year":"2015","journal-title":"Rheumatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101486","DOI":"10.1016\/j.berh.2020.101486","article-title":"Pitfalls in the diagnosis of myositis","volume":"34","author":"Chinoy","year":"2020","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.rdc.2019.07.006","article-title":"Idiopathic inflammatory myopathies","volume":"45","author":"Alexanderson","year":"2019","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.21037\/jtd.2017.02.75","article-title":"Cancer prevention from the perspective of global cancer burden patterns","volume":"9","author":"Nagai","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: A systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Wang","year":"2016","journal-title":"Lancet"},{"key":"ref_6","first-page":"489","article-title":"Polymyositis","volume":"53","author":"Stertz","year":"1916","journal-title":"Berl. Klin. Wochenschr."},{"key":"ref_7","first-page":"335","article-title":"Uber primare nichteitrige polymyositis","volume":"120","author":"Kankelheit","year":"1916","journal-title":"Dtsch. Arch. Klin. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.rdc.2020.05.006","article-title":"Risk factors and cancer screening in myositis","volume":"46","author":"Oddis","year":"2020","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/BOR.0000000000000641","article-title":"The role of cancer-associated autoantibodies as biomarkers in paraneoplastic myositis syndrome","volume":"31","author":"Lu","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00051675","article-title":"Cancer risk following polymyositis and dermatomyositis: A nationwide cohort study in Denmark","volume":"6","author":"Chow","year":"1995","journal-title":"Cancer Causes Control."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-4362.2002.01648.x","article-title":"Polymyositis and dermatomyositis associated with malignancy: A 30-year retrospective study: Polymyositis and dermatomyositis with malignancy","volume":"41","author":"Wakata","year":"2002","journal-title":"Int. J. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1196\/annals.1361.047","article-title":"Cancer-Associated Myositis: Clinical Features and Prognostic Signs","volume":"1051","author":"Ponyi","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","article-title":"Risk of Cancer in Patients with Dermatomyositis or Polymyositis","volume":"326","author":"Sigurgeirsson","year":"1992","journal-title":"New Engl. J. Med."},{"key":"ref_14","first-page":"438","article-title":"Dermatomyositis and polymyositis associated with malignancy: A 21-year retrospective study","volume":"35","author":"Ponyi","year":"2008","journal-title":"J. Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1203475416665601","article-title":"Risk of malignancy in dermatomyositis and polymyositis: A systematic review and meta-analysis","volume":"21","author":"Qiang","year":"2017","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-017-1469-8","article-title":"Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: A large longitudinal cohort study","volume":"19","author":"Yang","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/1756-185X.14046","article-title":"Risk factors for cancer-associated myositis: A large-scale multicenter cohort study","volume":"24","author":"Li","year":"2021","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","article-title":"The EuroMyositis registry: An international collaborative tool to facilitate myositis research","volume":"77","author":"Lilleker","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.bor.0000245721.02512.77","article-title":"Cancer and myositis: New insights into an old association","volume":"18","author":"Levine","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_20","first-page":"1749","article-title":"Retrospective Analysis of Cancer-Associated Myositis Patients over the Past 3 Decades in a Hungarian Myositis Cohort","volume":"26","author":"Bodoki","year":"2019","journal-title":"Pathol. Oncol. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00296-005-0005-3","article-title":"Paraneoplastic rheumatic syndromes","volume":"26","author":"Csiki","year":"2006","journal-title":"Rheumatol. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11926-011-0169-7","article-title":"Malignancy in myositis","volume":"13","author":"Zahr","year":"2011","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2133.2007.08055.x","article-title":"A systematic review of juvenile-onset clinically amyopathic dermatomyositis","volume":"157","author":"Gerami","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy: A population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00296-012-2489-y","article-title":"The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis","volume":"33","author":"Limaye","year":"2013","journal-title":"Rheumatol. Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.semarthrit.2015.06.005","article-title":"Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort","volume":"45","author":"Dobloug","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A novel autoantibody to a 155-kd protein is associated with dermatomyositis","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy","volume":"201","author":"Nagaraju","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2340\/00015555-1550","article-title":"TIF1\u03b3-overexpressing, highly progressive endometrial carcinoma in a patient with dermato-myositis positive for malignancy-associated anti-p155\/140 autoantibody","volume":"93","author":"Kasuya","year":"2013","journal-title":"Acta Derm. Venerol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1179\/174313208X281154","article-title":"Expression of myositis specific autoantigens during post-natal myogenesis","volume":"30","author":"Zampieri","year":"2008","journal-title":"Neurol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/ard.2005.040717","article-title":"Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 antigen","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.autrev.2009.12.005","article-title":"Polymyositis, dermatomyositis and malignancy: A further intriguing link","volume":"9","author":"Zampieri","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/rheumatology\/kex413","article-title":"Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis","volume":"57","author":"Balada","year":"2018","journal-title":"Rheumatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.nmd.2019.09.014","article-title":"Malignancy and myositis, from molecular mimicry to tumor infiltrating lymphocytes","volume":"29","author":"Ros","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3899\/jrheum.170544","article-title":"Increased levels of soluble programmed death ligand 1 associate with malignancy in patients with dermatomyositis","volume":"45","author":"Chen","year":"2018","journal-title":"J. Rheumatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.autrev.2011.10.024","article-title":"Hematological malignancy associated with polymyositis and dermatomyositis","volume":"11","author":"Marie","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1365-2133.2001.04140.x","article-title":"Predicting factors of malignancy in dermatomyositis and polymyositis: A case-control study","volume":"144","author":"Chen","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2133.2009.09274.x","article-title":"Malignancies associated with dermatomyositis and polymyositis in Taiwan: A nationwide population-based study","volume":"161","author":"Huang","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"509354","DOI":"10.1155\/2013\/509354","article-title":"Clinical features of inflammatory myopathies and their association with malignancy: A systematic review in asian population","volume":"2013","author":"Ungprasert","year":"2013","journal-title":"ISRN Rheumatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12016-015-8511-x","article-title":"Idiopathic inflammatory myopathies and malignancy: A comprehensive review","volume":"52","author":"Tiniakou","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_42","first-page":"1897","article-title":"Dermatomyositis and ovarian cancer: A report of 7 cases and literature review","volume":"20","author":"Cherin","year":"1993","journal-title":"J. Rheumatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s002960000070","article-title":"Primary lung cancer associated with polymyositis\/dermatomyositis, with a review of the literature","volume":"20","author":"Fujita","year":"2001","journal-title":"Rheumatol. Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0b013e31819da352","article-title":"Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis","volume":"88","author":"Fardet","year":"2009","journal-title":"Medicine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.3899\/jrheum.110320","article-title":"Idiopathic inflammatory myopathy associated with malignancy: A retrospective cohort of 151 korean patients with dermatomyositis and polymyositis","volume":"38","author":"So","year":"2011","journal-title":"J. Rheumatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3899\/jrheum.090549","article-title":"Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA","volume":"36","author":"Antiochos","year":"2009","journal-title":"J. Rheumatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1468-3083.2008.02971.x","article-title":"Clinical and biological factors predictive of malignancy in dermatomyositis","volume":"23","author":"Prohic","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/bjd.12564","article-title":"Meta-analysis of the association of dermatomyositis and polymyositis with cancer","volume":"169","author":"Wang","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Lu, X., Yang, H., Shu, X., Chen, F., Zhang, Y., Zhang, S., Peng, Q., Tian, X., and Wang, G. (2014). Factors predicting malignancy in patients with polymyositis and dermatomyostis: A systematic review and meta-analysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0094128"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00296-013-2910-1","article-title":"Cancer-associated myositis: A 35-year retrospective study of a monocentric cohort","volume":"34","author":"Neri","year":"2014","journal-title":"Rheumatol. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1054\/bjoc.2001.1699","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis and follow-up implications: A Scottish population-based cohort study","volume":"85","author":"Stockton","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/ar2987","article-title":"Cancer risks of dermatomyositis and polymyositis: A nationwide cohort study in Taiwan","volume":"12","author":"Chen","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1093\/rheumatology\/keab166","article-title":"A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies","volume":"60","author":"Oldroyd","year":"2021","journal-title":"Rheumatology"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Labeit, B., Pawlitzki, M., Ruck, T., Muhle, P., Claus, I., Suntrup-Krueger, S., Warnecke, T., Meuth, S.G., Wiendl, H., and Dziewas, R. (2020). The Impact of Dysphagia in Myositis: A Systematic Review and Meta-Analysis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072150"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.clineuro.2012.07.019","article-title":"Muscle biopsy findings predictive of malignancy in rare infiltrative dermatomyositis","volume":"115","author":"Uchino","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000051611","article-title":"Cutaneous leukocytoclastic vasculitis in dermatomyositis suggests malignancy","volume":"202","author":"Hunger","year":"2001","journal-title":"Dermatology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ad.2013.11.007","article-title":"Dermatomiositis paraneopl\u00e1sica: Estudio de 12 casos","volume":"105","author":"Requena","year":"2014","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.semarthrit.2008.09.003","article-title":"Nailfold capillary microscopy in adults with inflammatory myopathy","volume":"39","year":"2010","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_59","first-page":"165","article-title":"Usefulness of erythrocyte sedimentation rate as tumor marker in cancer associated dermatomyositis","volume":"12","author":"Amerio","year":"2002","journal-title":"Eur. J. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3389\/fonc.2019.00979","article-title":"The roles of TIF1\u03b3 in cancer","volume":"9","author":"Yu","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/25785826.2020.1791402","article-title":"Transcriptional intermediary factor 1 (TIF1) and anti-TIF1\u03b3 antibody-positive dermatomyositis","volume":"44","author":"Kotobuki","year":"2021","journal-title":"Immunol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e23307","DOI":"10.1002\/jcla.23307","article-title":"Analysis of myositis autoantibodies in Chinese patients with cancer-associated myositis","volume":"34","author":"Li","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s10067-019-04503-7","article-title":"The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies","volume":"38","author":"Li","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/art.40895","article-title":"The IgG2 isotype of anti\u2013transcription intermediary factor 1\u03b3 autoantibodies is a biomarker of cancer and mortality in adult dermatomyositis","volume":"71","author":"Aussy","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/rheumatology\/key310","article-title":"Changes in antibody titres in patients with anti-transcription intermediary factor 1-gamma antibody-positive idiopathic inflammatory myositis","volume":"58","author":"Abe","year":"2019","journal-title":"Rheumatology"},{"key":"ref_66","first-page":"990","article-title":"Strong correlation between cancer progression and anti-transcription intermediary factor 1\u03b3 antibodies in dermatomyositis patients","volume":"36","author":"Muro","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/08923973.2021.1910833","article-title":"Presence of anti-TIF-1\u03b3, anti-Ro52, anti-SSA\/Ro60 and anti-Su\/AgO2 antibodies in breast cancer: A cross-sectional study","volume":"43","year":"2021","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e11501","DOI":"10.1097\/MD.0000000000011501","article-title":"Anti-NXP2-antibody-positive immune-mediated necrotizing myopathy associated with acute myeloid leukemia","volume":"97","author":"Su","year":"2018","journal-title":"Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-020-00492-z","article-title":"Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children","volume":"19","author":"Wang","year":"2021","journal-title":"Pediatr. Rheumatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","article-title":"A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy","volume":"52","author":"Satoh","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3389\/fimmu.2017.00992","article-title":"Dermatomyositis and immune-mediated necrotizing myopathies: A window on autoimmunity and cancer","volume":"8","author":"Aussy","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","article-title":"Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: Possible association with malignancy","volume":"71","author":"Ichimura","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.38093","article-title":"Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1\u03b3: Antibodies to NXP-2 and TIF-1\u03b3 in cancer-associated dermatomyositis","volume":"65","author":"Fiorentino","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clim.2018.11.008","article-title":"Association of anti-nuclear matrix protein 2 antibody with complications in patients with idiopathic inflammatory myopathies: A meta-analysis of 20 cohorts","volume":"198","author":"Zhong","year":"2019","journal-title":"Clin. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.011","article-title":"Four dermatomyositis-specific autoantibodies\u2014anti-TIF1\u03b3, anti-NXP2, anti-SAE and anti-MDA5\u2014in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort","volume":"13","author":"Bodoki","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.autrev.2018.10.004","article-title":"Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays","volume":"18","author":"Damoiseaux","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: An important tool to support diagnosis of myositis","volume":"280","author":"Betteridge","year":"2016","journal-title":"J. Intern. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.autrev.2016.07.023","article-title":"Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study","volume":"15","author":"Musset","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/aww054","article-title":"High risk of cancer in autoimmune necrotizing myopathies: Usefulness of myositis specific antibody","volume":"139","author":"Allenbach","year":"2016","journal-title":"Brain"},{"key":"ref_80","first-page":"787","article-title":"More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"56","author":"Tiniakou","year":"2017","journal-title":"Rheumatology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1158\/1055-9965.EPI-04-0624","article-title":"Tumor antigen markers for the detection of solid cancers in inflammatory myopathies","volume":"14","author":"Amoura","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/gyno.1997.4666","article-title":"Serum CA-125 screening for ovarian cancer in patients with dermatomyositis","volume":"65","author":"Whitmore","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e9639","DOI":"10.1097\/MD.0000000000009639","article-title":"Evidence supports blind screening for internal malignancy in dermatomyositis: Data from 2 large US dermatology cohorts","volume":"97","author":"Leatham","year":"2018","journal-title":"Medicine"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archderm.138.7.885","article-title":"Routine vs. extensive malignancy search for adult dermatomyositis and polymyositis: A study of 40 patients","volume":"138","author":"Sparsa","year":"2002","journal-title":"Arch. Dermatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MNM.0000000000000981","article-title":"18F-FDG PET\/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications","volume":"40","author":"Maliha","year":"2019","journal-title":"Nucl. Med. Commun."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","article-title":"Conventional cancer screening versus PET\/CT in dermatomyositis\/polymyositis","volume":"123","author":"Grau","year":"2010","journal-title":"Am. J. Med."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/1\/111\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:01:56Z","timestamp":1760364116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/1\/111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["biom12010111"],"URL":"https:\/\/doi.org\/10.3390\/biom12010111","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]}}}